BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14582352)

  • 1. [Sports and doping].
    Yoshida T
    Chudoku Kenkyu; 2003 Jul; 16(3):299-305. PubMed ID: 14582352
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs in the Olympics.
    Med Lett Drugs Ther; 1984 Jul; 26(665):65-6. PubMed ID: 6146092
    [No Abstract]   [Full Text] [Related]  

  • 3. [Doping].
    Kawahara T
    Nihon Rinsho; 2000 Sep; 58 Suppl():162-6. PubMed ID: 11085108
    [No Abstract]   [Full Text] [Related]  

  • 4. [Doping].
    Clasing D
    Internist (Berl); 1986 Dec; 27(12):785-93. PubMed ID: 2880826
    [No Abstract]   [Full Text] [Related]  

  • 5. Ergogenic drugs in sports.
    Knopp WD; Wang TW; Bach BR
    Clin Sports Med; 1997 Jul; 16(3):375-92. PubMed ID: 9209817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance-enhancing drugs.
    Med Lett Drugs Ther; 2004 Jul; 46(1187):57-9. PubMed ID: 15263874
    [No Abstract]   [Full Text] [Related]  

  • 7. [Doping agents and their analytical control].
    Szókán G
    Acta Pharm Hung; 2002; 72(4):231-44. PubMed ID: 12812043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doping control].
    Ueki M; Kuroda Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1270-5. PubMed ID: 1972422
    [No Abstract]   [Full Text] [Related]  

  • 10. [Doping].
    Kamber M; Villard G
    Praxis (Bern 1994); 1995 Sep; 84(36):970-7. PubMed ID: 7481289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs in sports.
    Mofenson HC; Greensher J
    N Y State J Med; 1980 Jan; 80(1):57-60. PubMed ID: 6102364
    [No Abstract]   [Full Text] [Related]  

  • 12. [Doping tests in Switzerland].
    Bäumler J
    Schweiz Z Sportmed; 1980 Sep; 28(4):97-103. PubMed ID: 7209481
    [No Abstract]   [Full Text] [Related]  

  • 13. [Doping control in race horses].
    Ungemach FR
    Tierarztl Prax; 1985; 13(1):35-53. PubMed ID: 2859671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anti-doping sampling strategy utilizing the sewerage systems of sport villages.
    Katsoyiannis A; Jones KC
    Environ Sci Technol; 2011 Jan; 45(2):362-3. PubMed ID: 21142144
    [No Abstract]   [Full Text] [Related]  

  • 15. History of doping and doping control.
    Müller RK
    Handb Exp Pharmacol; 2010; (195):1-23. PubMed ID: 20020358
    [No Abstract]   [Full Text] [Related]  

  • 16. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M; Schänzer W
    Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use in athletics: a sports psychiatry perspective.
    McDuff DR; Baron D
    Clin Sports Med; 2005 Oct; 24(4):885-97, ix-x. PubMed ID: 16169452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular complications of doping products].
    Demoulin R; Poyet R; Capilla E; Tortat AV; Pons F; Brocq FX; Druelle A; Jego C; Foucault G; Cellarier GR
    Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):365-369. PubMed ID: 30290907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Many "doping pitfalls" in spite of safe measurement methods].
    Nystrand A
    Lakartidningen; 1996 Jul; 93(28-29):2570-6. PubMed ID: 8766754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.